{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:53:42Z","timestamp":1794873222033,"version":"4.9.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA222571"],"award-info":[{"award-number":["R01CA222571"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR070877"],"award-info":[{"award-number":["R01AR070877"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58809-z","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:47:14Z","timestamp":1744714034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8922-9976","authenticated-orcid":false,"given":"Yuchen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-1300","authenticated-orcid":false,"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-372X","authenticated-orcid":false,"given":"Huiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-887X","authenticated-orcid":false,"given":"Yingzi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"58809_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"JYL Chiang","year":"2019","unstructured":"Chiang, J. Y. L. & Ferrell, J. M. Bile Acids as Metabolic Regulators and Nutrient Sensors. Annu Rev. Nutr. 39, 175\u2013200 (2019).","journal-title":"Annu Rev. Nutr."},{"key":"58809_CR2","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-019-0660-7","volume":"25","author":"F Segovia-Miranda","year":"2019","unstructured":"Segovia-Miranda, F. et al. Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression. Nat. Med. 25, 1885\u20131893 (2019).","journal-title":"Nat. Med."},{"key":"58809_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PL Jansen","year":"2017","unstructured":"Jansen, P. L. et al. The ascending pathophysiology of cholestatic liver disease. Hepatology 65, 722\u2013738 (2017).","journal-title":"Hepatology"},{"key":"58809_CR4","doi-asserted-by":"publisher","unstructured":"Davit-Spraul, A., Gonzales, E., Baussan, C. & Jacquemin, E. Progressive familial intrahepatic cholestasis. Orphanet. J. Rare Dis. 4, 1. https:\/\/doi.org\/10.1186\/1750-1172-4-1. (2009)","DOI":"10.1186\/1750-1172-4-1"},{"key":"58809_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/eci.12128","volume":"43","author":"C Jungst","year":"2013","unstructured":"Jungst, C. et al. Intrahepatic cholestasis in common chronic liver diseases. Eur. J. Clin. Invest 43, 1069\u20131083 (2013).","journal-title":"Eur. J. Clin. Invest"},{"key":"58809_CR6","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","volume":"139","author":"GM Hirschfield","year":"2010","unstructured":"Hirschfield, G. M., Heathcote, E. J. & Gershwin, M. E. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 139, 1481\u20131496 (2010).","journal-title":"Gastroenterology"},{"key":"58809_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3748\/wjg.v9.i3.385","volume":"9","author":"LX Qin","year":"2003","unstructured":"Qin, L. X. & Tang, Z. Y. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J. Gastroenterol. 9, 385\u2013391 (2003).","journal-title":"World J. Gastroenterol."},{"key":"58809_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","volume":"18","author":"L Sun","year":"2021","unstructured":"Sun, L., Cai, J. & Gonzalez, F. J. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 18, 335\u2013347 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"58809_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin, B. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517\u2013526 (2000).","journal-title":"Mol. Cell"},{"key":"58809_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","volume":"6","author":"TT Lu","year":"2000","unstructured":"Lu, T. T. et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6, 507\u2013515 (2000).","journal-title":"Mol. Cell"},{"key":"58809_CR11","doi-asserted-by":"publisher","first-page":"28857","DOI":"10.1074\/jbc.M011610200","volume":"276","author":"M Ananthanarayanan","year":"2001","unstructured":"Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J. & Suchy, F. J. Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor. J. Biol. Chem. 276, 28857\u201328865 (2001).","journal-title":"J. Biol. Chem."},{"key":"58809_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","volume":"102","author":"CJ Sinal","year":"2000","unstructured":"Sinal, C. J. et al. Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis. Cell 102, 731\u2013744 (2000).","journal-title":"Cell"},{"key":"58809_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","volume":"67","author":"F Yang","year":"2007","unstructured":"Yang, F. et al. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 67, 863\u2013867 (2007).","journal-title":"Cancer Res."},{"key":"58809_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/carcin\/bgl249","volume":"28","author":"I Kim","year":"2007","unstructured":"Kim, I. et al. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28, 940\u2013946 (2007).","journal-title":"Carcinogenesis"},{"key":"58809_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.celrep.2013.10.030","volume":"5","author":"S Anakk","year":"2013","unstructured":"Anakk, S. et al. Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 5, 1060\u20131069 (2013).","journal-title":"Cell Rep."},{"key":"58809_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/hep4.1263","volume":"2","author":"S Takahashi","year":"2018","unstructured":"Takahashi, S. et al. Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development. Hepatol. Commun. 2, 1567\u20131582 (2018).","journal-title":"Hepatol. Commun."},{"key":"58809_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","volume":"50","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y. & Pan, D. The Hippo Signaling Pathway in Development and Disease. Dev. Cell 50, 264\u2013282 (2019).","journal-title":"Dev. Cell"},{"key":"58809_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI88486","volume":"127","author":"W Kim","year":"2017","unstructured":"Kim, W. et al. Hippo signaling interactions with Wnt\/beta-catenin and Notch signaling repress liver tumorigenesis. J. Clin. Invest 127, 137\u2013152 (2017).","journal-title":"J. Clin. Invest"},{"key":"58809_CR19","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/gutjnl-2017-314061","volume":"67","author":"W Kim","year":"2018","unstructured":"Kim, W. et al. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut 67, 1692\u20131703 (2018).","journal-title":"Gut"},{"key":"58809_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2021.11.010","volume":"76","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis. J. Hepatol. 76, 652\u2013664 (2022).","journal-title":"J. Hepatol."},{"key":"58809_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","volume":"19","author":"JO Russell","year":"2022","unstructured":"Russell, J. O. & Camargo, F. D. Hippo signalling in the liver: role in development, regeneration and disease. Nat. Rev. Gastroenterol. Hepatol. 19, 297\u2013312 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"58809_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","volume":"13","author":"J Zeng","year":"2023","unstructured":"Zeng, J., Fan, J. & Zhou, H. Bile acid-mediated signaling in cholestatic liver diseases. Cell Biosci. 13, 77 (2023).","journal-title":"Cell Biosci."},{"key":"58809_CR23","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","volume":"157","author":"D Yimlamai","year":"2014","unstructured":"Yimlamai, D. et al. Hippo pathway activity influences liver cell fate. Cell 157, 1324\u20131338 (2014).","journal-title":"Cell"},{"key":"58809_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120\u20131133 (2007).","journal-title":"Cell"},{"key":"58809_CR25","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054\u20132060 (2007).","journal-title":"Curr. Biol."},{"key":"58809_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1478-3231.2007.01506.x","volume":"27","author":"G Zollner","year":"2007","unstructured":"Zollner, G. et al. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int. 27, 920\u2013929 (2007).","journal-title":"Liver Int."},{"key":"58809_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/hep.22771","volume":"49","author":"FG Schaap","year":"2009","unstructured":"Schaap, F. G., van der Gaag, N. A., Gouma, D. J. & Jansen, P. L. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 49, 1228\u20131235 (2009).","journal-title":"Hepatology"},{"key":"58809_CR28","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","volume":"3","author":"KM Schneider","year":"2021","unstructured":"Schneider, K. M. et al. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling. Nat. Metab. 3, 1228\u20131241 (2021).","journal-title":"Nat. Metab."},{"key":"58809_CR29","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.ajpath.2018.05.015","volume":"188","author":"R Liu","year":"2018","unstructured":"Liu, R., Li, X., Hylemon, P. B. & Zhou, H. Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation. Am. J. Pathol. 188, 2042\u20132058 (2018).","journal-title":"Am. J. Pathol."},{"key":"58809_CR30","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Generation and characterization of mature hepatocyte organoids for liver metabolic studies. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.261961. (2024)","DOI":"10.1242\/jcs.261961"},{"key":"58809_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"58809_CR32","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1021\/jm0002127","volume":"43","author":"PR Maloney","year":"2000","unstructured":"Maloney, P. R. et al. Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med Chem. 43, 2971\u20132974 (2000).","journal-title":"J. Med Chem."},{"key":"58809_CR33","doi-asserted-by":"publisher","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","volume":"273","author":"T Gerloff","year":"1998","unstructured":"Gerloff, T. et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 273, 10046\u201310050 (1998).","journal-title":"J. Biol. Chem."},{"key":"58809_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep.21287","volume":"44","author":"AS Knisely","year":"2006","unstructured":"Knisely, A. S. et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44, 478\u2013486 (2006).","journal-title":"Hepatology"},{"key":"58809_CR35","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0016-5085(99)70287-8","volume":"117","author":"PL Jansen","year":"1999","unstructured":"Jansen, P. L. et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 117, 1370\u20131379 (1999).","journal-title":"Gastroenterology"},{"key":"58809_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/3034","volume":"20","author":"SS Strautnieks","year":"1998","unstructured":"Strautnieks, S. S. et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet 20, 233\u2013238 (1998).","journal-title":"Nat. Genet"},{"key":"58809_CR37","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","volume":"98","author":"R Wang","year":"2001","unstructured":"Wang, R. et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc. Natl Acad. Sci. USA 98, 2011\u20132016 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58809_CR38","unstructured":"In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (2012)."},{"key":"58809_CR39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/hep.30810","volume":"71","author":"JD Schumacher","year":"2020","unstructured":"Schumacher, J. D. et al. Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development. Hepatology 71, 670\u2013685 (2020).","journal-title":"Hepatology"},{"key":"58809_CR40","unstructured":"Patton, M. E. et al. (eLife Sciences Publications, Ltd, 2024)."},{"key":"58809_CR41","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1021\/jm025529g","volume":"45","author":"R Pellicciari","year":"2002","unstructured":"Pellicciari, R. et al. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J. Med. Chem. 45, 3569\u20133572 (2002).","journal-title":"J. Med. Chem."},{"key":"58809_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI68815","volume":"124","author":"F Lien","year":"2014","unstructured":"Lien, F. et al. Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. J. Clin. Invest 124, 1037\u20131051 (2014).","journal-title":"J. Clin. Invest"},{"key":"58809_CR43","doi-asserted-by":"publisher","unstructured":"Mathur, B. et al. Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver. Sci. Adv. 7. https:\/\/doi.org\/10.1126\/sciadv.abf4865. (2021)","DOI":"10.1126\/sciadv.abf4865"},{"key":"58809_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.devcel.2018.12.021","volume":"48","author":"S Ji","year":"2019","unstructured":"Ji, S. et al. FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis. Dev. Cell 48, 460\u2013474 e469 (2019).","journal-title":"Dev. Cell"},{"key":"58809_CR45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1073\/pnas.0911409107","volume":"107","author":"H Song","year":"2010","unstructured":"Song, H. et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl Acad. Sci. USA 107, 1431\u20131436 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58809_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425\u2013438 (2009).","journal-title":"Cancer Cell"},{"key":"58809_CR47","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl Acad. Sci. USA 107, 1437\u20131442 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58809_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206113119","volume":"119","author":"NR Kastan","year":"2022","unstructured":"Kastan, N. R. et al. Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs. Proc. Natl Acad. Sci. USA 119, e2206113119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58809_CR49","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300\u20131305 (2012).","journal-title":"Genes Dev."},{"key":"58809_CR50","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng.3547","volume":"48","author":"A Fujimoto","year":"2016","unstructured":"Fujimoto, A. et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat. Genet 48, 500\u2013509 (2016).","journal-title":"Nat. Genet"},{"key":"58809_CR51","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971 (2008).","journal-title":"Genes Dev."},{"key":"58809_CR52","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.celrep.2013.11.021","volume":"5","author":"TA Beyer","year":"2013","unstructured":"Beyer, T. A. et al. Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 5, 1611\u20131624 (2013).","journal-title":"Cell Rep."},{"key":"58809_CR53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.celrep.2015.03.015","volume":"11","author":"M Kim","year":"2015","unstructured":"Kim, M., Kim, T., Johnson, R. L. & Lim, D. S. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep. 11, 270\u2013282 (2015).","journal-title":"Cell Rep."},{"key":"58809_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108284","volume":"33","author":"L He","year":"2020","unstructured":"He, L. et al. A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis. Cell Rep. 33, 108284 (2020).","journal-title":"Cell Rep."},{"key":"58809_CR55","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1093\/nar\/gkac624","volume":"50","author":"F Biagioni","year":"2022","unstructured":"Biagioni, F. et al. Decoding YAP dependent transcription in the liver. Nucleic Acids Res. 50, 7959\u20137971 (2022).","journal-title":"Nucleic Acids Res."},{"key":"58809_CR56","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1053\/j.gastro.2020.07.036","volume":"159","author":"JM Ramos Pittol","year":"2020","unstructured":"Ramos Pittol, J. M. et al. FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs. Gastroenterology 159, 1853\u20131865 e1810 (2020).","journal-title":"Gastroenterology"},{"key":"58809_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore, P. I. et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143\u20131149 (2015).","journal-title":"Nat. Methods"},{"key":"58809_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","volume":"25","author":"S Jiao","year":"2014","unstructured":"Jiao, S. et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25, 166\u2013180 (2014).","journal-title":"Cancer Cell"},{"key":"58809_CR59","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/onc.2017.24","volume":"36","author":"Z Shi","year":"2017","unstructured":"Shi, Z. et al. DNA-binding mechanism of the Hippo pathway transcription factor TEAD4. Oncogene 36, 4362\u20134369 (2017).","journal-title":"Oncogene"},{"key":"58809_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont, S. et al. Role of YAP\/TAZ in mechanotransduction. Nature 474, 179\u2013183 (2011).","journal-title":"Nature"},{"key":"58809_CR61","doi-asserted-by":"publisher","first-page":"35086","DOI":"10.1074\/jbc.M803531200","volume":"283","author":"S Fang","year":"2008","unstructured":"Fang, S. et al. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP. J. Biol. Chem. 283, 35086\u201335095 (2008).","journal-title":"J. Biol. Chem."},{"key":"58809_CR62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko, L. M. et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature 550, 128\u2013132 (2017).","journal-title":"Nature"},{"key":"58809_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg, K. J. & Johnstone, R. W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673\u2013691 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"58809_CR64","doi-asserted-by":"publisher","first-page":"G295","DOI":"10.1152\/ajpgi.00134.2015","volume":"310","author":"B Kong","year":"2016","unstructured":"Kong, B. et al. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G295\u2013G302 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"58809_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2019.04.004","volume":"25","author":"BJ Pepe-Mooney","year":"2019","unstructured":"Pepe-Mooney, B. J. et al. Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration. Cell Stem Cell 25, 23\u201338 e28 (2019).","journal-title":"Cell Stem Cell"},{"key":"58809_CR66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.331546.119","volume":"34","author":"JH Koo","year":"2020","unstructured":"Koo, J. H. et al. Induction of AP-1 by YAP\/TAZ contributes to cell proliferation and organ growth. Genes Dev. 34, 72\u201386 (2020).","journal-title":"Genes Dev."},{"key":"58809_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 7, 6 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"58809_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1121435","volume":"312","author":"W Huang","year":"2006","unstructured":"Huang, W. et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312, 233\u2013236 (2006).","journal-title":"Science"},{"key":"58809_CR69","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/hep.27085","volume":"60","author":"R Liu","year":"2014","unstructured":"Liu, R. et al. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology 60, 908\u2013918 (2014).","journal-title":"Hepatology"},{"key":"58809_CR70","doi-asserted-by":"publisher","first-page":"30988","DOI":"10.1074\/jbc.M115.668277","volume":"290","author":"R Liu","year":"2015","unstructured":"Liu, R. et al. Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line. J. Biol. Chem. 290, 30988\u201331002 (2015).","journal-title":"J. Biol. Chem."},{"key":"58809_CR71","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1053\/j.gastro.2020.10.035","volume":"160","author":"E Verboven","year":"2021","unstructured":"Verboven, E. et al. Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis. Gastroenterology 160, 847\u2013862 (2021).","journal-title":"Gastroenterology"},{"key":"58809_CR72","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molcel.2015.09.001","volume":"60","author":"GG Galli","year":"2015","unstructured":"Galli, G. G. et al. YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers. Mol. Cell 60, 328\u2013337 (2015).","journal-title":"Mol. Cell"},{"key":"58809_CR73","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","volume":"54","author":"BK Wu","year":"2022","unstructured":"Wu, B. K., Mei, S. C., Chen, E. H., Zheng, Y. & Pan, D. YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis. Nat. Genet 54, 1202\u20131213 (2022).","journal-title":"Nat. Genet"},{"key":"58809_CR74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1101\/gad.294348.116","volume":"31","author":"X Guo","year":"2017","unstructured":"Guo, X. et al. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev. 31, 247\u2013259 (2017).","journal-title":"Genes Dev."},{"key":"58809_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28691-0","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma, S. et al. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER(+) breast cancer. Nat. Commun. 13, 1061 (2022).","journal-title":"Nat. Commun."},{"key":"58809_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30831-5","volume":"13","author":"X Li","year":"2022","unstructured":"Li, X. et al. YAP inhibits ERalpha and ER(+) breast cancer growth by disrupting a TEAD-ERalpha signaling axis. Nat. Commun. 13, 3075 (2022).","journal-title":"Nat. Commun."},{"key":"58809_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52757-w","volume":"15","author":"TA Kluiver","year":"2024","unstructured":"Kluiver, T. A. et al. Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids. Nat. Commun. 15, 8576 (2024).","journal-title":"Nat. Commun."},{"key":"58809_CR78","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways. Cells 10. https:\/\/doi.org\/10.3390\/cells10020210. (2021)","DOI":"10.3390\/cells10020210"},{"key":"58809_CR79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"58809_CR80","doi-asserted-by":"publisher","first-page":"e15543","DOI":"10.1371\/journal.pone.0015543","volume":"5","author":"Y Hoshida","year":"2010","unstructured":"Hoshida, Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS One 5, e15543 (2010).","journal-title":"PLoS One"},{"key":"58809_CR81","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nat. Genet 38, 500\u2013501 (2006).","journal-title":"Nat. Genet"},{"key":"58809_CR82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"58809_CR83","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ramirez","year":"2014","unstructured":"Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res."},{"key":"58809_CR84","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58809-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58809-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58809-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:03:55Z","timestamp":1744722235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58809-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58809"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58809-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3583"}}